S&P Global revises outlook on Meta to negative on cashflow concerns

More in Finance

• Cramer’s week ahead: Expect more volatility as tech earnings, midterms loom

  Investors face persistent market swings as corporate earnings, political shifts, and fresh macroeconomic data threaten to test equity valuations. Ongoing skepticism surrounding the artificial intelligence trade has already triggered sharp weekly pullbacks across major U.S. indexes. Navigating these near-term crosscurrents will require caution, particularly with shifting political dynamics capable of disrupting critical tech infrastructure development.

  3 min read
• Meta outlook revised to negative by S&P on cash flow and capex concerns

  Escalating investments in artificial intelligence have begun to strain the tech giant's balance sheet, prompting credit agencies to flag rising financial risks. Wall Street reacted swiftly to these liquidity concerns, sending the company's equity into its steepest monthly downturn in four years. To offset heavy operational drains, management is now executing a massive multibillion-dollar financing plan across public equity markets.

  1 min read
• Why is Inovio Pharmaceuticals stock surging today?

  Investors are bidding up shares of Inovio Pharmaceuticals during current trading hours. Market participants are monitoring the biotechnology firm closely as its equity experiences substantial upward movement. Additional information regarding the specific drivers behind this market activity remains limited at this time.

  1 min read